✦ LIBER ✦

Improvement in behavioral and psychiatric SYMPTOMS (BPSD) in patients with moderate-to-severe Alzheimer's disease by current antidementia treatments

✍ Scribed by Cumbo, Eduardo

Book ID: 122672264
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 46 KB
Volume: 7
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2011.05.2225

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improvement in behavioural symptoms in p

Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis

✍ S. Gauthier; H. Loft; J. Cummings 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Abstract ## Introduction Behavioural disturbances are a common and distressing aspect of Alzheimer's disease (AD). This pooled analysis evaluated the specific benefits of memantine on behavioural disturbances in patients with moderate to severe AD. ## Methods Data were pooled from six 24/28‐w

Memantine Therapy of Behavioral Symptoms

Memantine Therapy of Behavioral Symptoms in Community-Dwelling Patients with Moderate to Severe Alzheimer’s Disease

✍ Grossberg, George T.; Pejovi&cacute;, Vojislav; Miller, Michael L.; Graham, Step 📂 Article 📅 2009 🏛 S. Karger AG 🌐 English ⚖ 227 KB

Combination therapy with galantamine and

Combination therapy with galantamine and memantine improves behavioral and psychological symptoms of dementia (BPSD) in patients with early-onset Alzheimer's disease

✍ Hamuro, A. 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 656 KB

Acceptability and clinical activity of 4

Acceptability and clinical activity of 4 weeks' treatment by S12024-2 in 53 in-patients with moderate to severe Alzheimer's disease

✍ Stefas, E.; Papastefanou, M.; Patrelis, A.; Tzanos, I.A.; Tziotzou, K. 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 350 KB

P4-329: Post HOC responder analyses of M

P4-329: Post HOC responder analyses of Memantine treatment on behavioral disturbances in patients with moderate to severe Alzheimer's disease

✍ Stender, Karina; Cummings, Jeffrey 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Rivastigmine monotherapy and combination

Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment

✍ T. Dantoine; S. Auriacombe; M. Sarazin; H. Becker; J-J Pere; I. Bourdeix 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB